Navigation Links
CareGiver, Ventana Medical Systems, Inc. Remote Instrument Support, Has Expanded to Include the Ventana BenchMark ULTRA Automated Stainer

TUCSON, Ariz., Jan. 13, 2011 /PRNewswire/ -- CareGiver remote instrument support has expanded to include the Ventana BenchMark ULTRA automated stainer. Ventana Medical System, Inc. ("VMSI") is the leading innovator in the application of remote services for histology with over 5 years of success on the SYMPHONY H&E slide stainer. VMSI is now introducing remote service monitoring on BenchMark ULTRA, strengthening the integration of the SYMPHONY and BenchMark platforms. For customers, CareGiver reduces the prospect of unwanted surprises by monitoring instrument performance 24/7. "CareGiver changes the traditional service model from reactive to proactive," added Dave Flaten, International Business Leader for VMSI's Advanced Staining Platforms. "Customers are delighted when we call them to troubleshoot an instrument issue before they are aware of it. The integration of CareGiver remote instrument support on two key VMSI platforms will continue to drive financial performance, improve customer satisfaction, and further differentiate VMSI products from competitive systems and services," Flaten added.

When a laboratory instrument fails to perform as expected, documenting the issue with customer support, ordering parts, and waiting for an engineer to be dispatched can be an inconvenient and costly proposition for the lab, as the devices that facilitate reporting of patient results are mission critical. With CareGiver remote instrument support, VMSI continues to innovate the way customers experience the delivery of service for their instruments, as the VMSI customer support team can proactively monitor instrument performance remotely from their location in Tucson. "Increased uptime and access to instruments translate into improved customer satisfaction and increased productivity, which ultimately contributes to our key results," Flaten commented.

CareGiver Delivers Key Results

VMSI's innovative approach to service delivery allows the company to grow revenue through creative service offerings, differentiating products, and driving product and service revenue through increased maintenance contract renewals.

Moreover, the value of continuous remote services is in the reduction of services costs through improved analysis and dispatching of field resources, such that when service engineers are dispatched to a site, issues will already be remotely diagnosed, parts ordered, and materials delivered. The current practice of dispatching resources, having the field service engineer define and diagnose issues onsite, and then ordering the part for later repair wastes considerable time and money from a service perspective. Additionally, it creates an overall negative experience for the customer. CareGiver delivers a whole new paradigm of service delivery.

CareGiver remote instrument support is being commercialized on BenchMark ULTRA platform through a phased implementation approach. The service will be provided for North American systems in Q4 2010, with a planned launch in Europe and the rest of the world in early 2011. Ventana looks forward to continuing its expansion of CareGiver to more products in the advanced staining portfolio and expanding the application's capabilities on both Ventana SYMPHONY and BenchMark ULTRA stainers, effectively enhancing both its commercial objectives and customers' experiences in the process.

About Ventana Medical Systems, Inc.

Ventana Medical Systems, Inc. ("VMSI") develops, manufactures, and markets instrument/reagent systems that automate tissue preparation and slide staining in clinical histology and drug discovery laboratories worldwide. The Company's clinical systems are important tools used in the diagnosis and treatment of cancer and infectious diseases. VMSI's drug discovery systems are used to accelerate the discovery of new drug targets and evaluate the safety of new drug compounds. In addition, the Company offers premier workflow solutions designed to improve laboratory efficiency, providing safeguards to enhance the quality of healthcare. Ventana Medical Systems, Inc. is a wholly-owned member of the Roche Group. For more information on Ventana Medical Systems, Inc. visit

Ventana, the Ventana logo, SYMPHONY, and BenchMark are trademarks of Roche.

SOURCE Ventana Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Endologix Announces First Clinical Implant of Ventana™ Stent Graft
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Globus Medical Raises $110 Million in Series E Financing Round
6. Quark Pharmaceuticals Appoints New Chief Medical Officer
7. Boston University Biomedical Engineers Find Chink in Bacterias Armor
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
10. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
11. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
Post Your Comments:
(Date:10/13/2015)...  Synapse Biomedical Inc. ( ) reported today ... the use of the NeuRx ® Diaphragm Pacing ... the United States and ... The PAS study group met their initial enrollment goal ... since expanded the enrollment target to 150 participants.   ...
(Date:10/13/2015)... , Oct. 13 2015 ... the "US & European markets for Meniscal ... their offering. --> ) has ... European markets for Meniscal Repair - 16 Countries ... Research and Markets ( ) has ...
(Date:10/13/2015)... Research and Markets ( ) has ... Types (Bacteria, Yeast, Mold, Others), Flavors (Herbs & Spices, ... by Region - Forecasts to 2020" report to ... --> The global market for kombucha ... terms of value, the market is projected to reach ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... 13, 2015 , ... According to an article published October 5th ... who successfully lose weight with a bariatric procedure are much less likely to develop ... notes that anywhere from 40 to 50 percent of all endometrial cancer cases are ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... In an ... utility costs were 36 percent lower per square foot than in 2009. The Williamsport ... cost of heating and cooling has decreased by eight percent. , According to ...
(Date:10/13/2015)... ... ... A child without a healthy mouth is much more likely to have an ... has joined with Global Dental Relief (GDR) to help bring dental care ... SmileCareClub will donate one clinic visit to a child in Kenya. , “When SmileCareClub ...
(Date:10/13/2015)... ... 13, 2015 , ... Scientists in Seattle and Vancouver compared the diagnostic value ... without mesothelioma. Surviving Mesothelioma has just posted an article on the new research. ... Seattle and the University of British Columbia found that certain genetic alterations were seen ...
(Date:10/13/2015)... , ... October 13, 2015 , ... World Patent ... Snow Blanket, a snow melting invention that helps people in clearing snow away from ... will continue to grow at 3.8% per year," says Scott Cooper, CEO and Creative ...
Breaking Medicine News(10 mins):